In recent years, shreds of evidence have arisen that the overexpression of CENPF was a frequent behavior in different malignant tumors and was closely related to the tumor deterioration and dismal prognosis in multiple neoplasms, including HCC [19, 20], breast cancer [23], prostate cancer [22] and other tumors [24]. The gene discussed is CENPF; the disease is breast carcinoma.